Concepedia

Duygu Ozmadenci

DO

6

Publications

359

Citations

6

H-Index

2015

Active since

Affiliations

Fox Chase Cancer Center(Current)

Moores Cancer Center

Verastem (United States)

Xiamen University

University of California San Diego

Duygu Ozmadenci is an author at Fox Chase Cancer Center specializing in cell biology, medicine, and ovarian cancer.

ORCID

Top concepts

Publications per year

2015–2022

6

Publications

6

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

Carlos J. Díaz Osterman, Duygu Ozmadenci, Elizabeth G. Kleinschmidt et al. · eLife · 2019 · 133 citations · Full text

Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis

Duygu Ozmadenci, Jayanth S. Shankara Narayanan, Jacob R. Andrew et al. · Proceedings of the National Academy of Sciences · 2022 · 70 citations · Full text

, , +19

Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance

Duygu Ozmadenci, Olivier Féraud, Suzy Markossian et al. · Nature Communications · 2015 · 50 citations · Full text

Netrin-1 promotes naive pluripotency through Neo1 and Unc5b co-regulation of Wnt and MAPK signalling

Aurélia Huyghe, Giacomo Furlan, Duygu Ozmadenci et al. · Nature Cell Biology · 2020 · 47 citations · Full text

, , +7

Rgnef promotes ovarian tumor progression and confers protection from oxidative stress

Elizabeth G. Kleinschmidt, Nichol Miller, Duygu Ozmadenci et al. · Oncogene · 2019 · 38 citations · Full text

, , +9

Rows per page

1–5 of 6